MP
Therapeutic Areas
EUROIMMUN Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Neurological CBA Portfolio Expansion | Autoimmune Encephalitis, Paraneoplastic Neurological Syndromes | Development/Commercial |
| Infectious Disease Serology Assays | Arboviral infections (e.g., Oropouche, Alphaviruses) | Development/Commercial |
| Automation Platform Integration | Assay migration to IDS i20 system | Development/Commercial |